These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 8494935)

  • 1. Initial hypoalbuminemia and hyperlipidemia persist during chronic peritoneal dialysis in children.
    Scolnik D; Balfe JW
    Perit Dial Int; 1993; 13(2):136-9. PubMed ID: 8494935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperlipidemia in pediatric patients undergoing peritoneal dialysis.
    Querfeld U; Salusky IB; Nelson P; Foley J; Fine RN
    Pediatr Nephrol; 1988 Oct; 2(4):447-52. PubMed ID: 3153058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperlipidemia in children on peritoneal dialysis: effect of energy intake on serum triglyceride.
    Tanaka Y; Hataya H; Araki Y; Ikeda M; Matsuyama T; Honda M
    Perit Dial Int; 2002; 22(3):426-8. PubMed ID: 12227408
    [No Abstract]   [Full Text] [Related]  

  • 4. Lipoprotein abnormalities in hemodialysis and continuous ambulatory peritoneal dialysis patients.
    Fytili CI; Progia EG; Panagoutsos SA; Thodis ED; Passadakis PS; Sombolos KI; Vargemezis VA
    Ren Fail; 2002 Sep; 24(5):623-30. PubMed ID: 12380908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous ambulatory and continuous cycling peritoneal dialysis in children. A report of the Southwest Pediatric Nephrology Study Group.
    Kidney Int; 1985 Mar; 27(3):558-64. PubMed ID: 3999544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of hyperlipidemia in a cohort of CAPD patients. Italian Cooperative Peritoneal Dialysis Study Group (ICPDSG).
    Cocchi R; Viglino G; Cancarini G; Catizone L; Favazza A; Tommasi A; Salomone M; Segoloni GP; Torpia R; Giangrande A
    Miner Electrolyte Metab; 1996; 22(1-3):22-5. PubMed ID: 8676819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid parameters including lipoprotein (a) in patients undergoing CAPD and hemodialysis.
    Siamopoulos KC; Elisaf MS; Bairaktari HT; Pappas MB; Sferopoulos GD; Nikolakakis NG
    Perit Dial Int; 1995; 15(8):342-7. PubMed ID: 8785232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneity in peritoneal transport during continuous ambulatory peritoneal dialysis and its impact on ultrafiltration, loss of macromolecules and plasma level of proteins, lipids and lipoproteins.
    Kagan A; Bar-Khayim Y; Schafer Z; Fainaru M
    Nephron; 1993; 63(1):32-42. PubMed ID: 8446249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The uremic dyslipidemia: a cross-sectional and longitudinal study.
    Avram MM; Goldwasser P; Burrell DE; Antignani A; Fein PA; Mittman N
    Am J Kidney Dis; 1992 Oct; 20(4):324-35. PubMed ID: 1415199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Residual renal function affects lipid profile in patients undergoing continuous ambulatory peritoneal dialysis.
    Kagan A; Elimalech E; Lemer Z; Fink A; Bar-Khayim Y
    Perit Dial Int; 1997; 17(3):243-9. PubMed ID: 9237284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating soluble vascular cell adhesion molecule 1: relationships with residual renal function, cardiac hypertrophy, and outcome of peritoneal dialysis patients.
    Wang AY; Lam CW; Wang M; Woo J; Chan IH; Lui SF; Sanderson JE; Li PK
    Am J Kidney Dis; 2005 Apr; 45(4):715-29. PubMed ID: 15806475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of peritoneal dialysis method on residual renal function in children.
    Roszkowska-Blaim M; Skrzypczyk P; Jander A; Tkaczyk M; Bałasz-Chmielewska I; Zurowska A; Drozdz D; Pietrzyk JA
    Adv Perit Dial; 2012; 28():112-9. PubMed ID: 23311226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Six-month prospective cross-over study to determine the effects of 1.1% amino acid dialysate on lipid metabolism in patients on continuous ambulatory peritoneal dialysis.
    Misra M; Reaveley DA; Ashworth J; Muller B; Seed M; Brown EA
    Perit Dial Int; 1997; 17(3):279-86. PubMed ID: 9237290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Children with hypoalbuminemia on continuous peritoneal dialysis are at risk for technique failure.
    Gulati S; Stephens D; Balfe JA; Secker D; Harvey E; Balfe JW
    Kidney Int; 2001 Jun; 59(6):2361-7. PubMed ID: 11380841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is atherosclerosis accelerated by CAPD?
    Kawaguchi Y; Kubo H; Yamamoto H; Nakayama M; Yokoyama K; Shigematsu T; Sakai O
    Perit Dial Int; 1996; 16 Suppl 1():S223-30. PubMed ID: 8728197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Metabolic parameters of CAPD and CCPD in diabetics with terminal renal insufficiency].
    Thomae U; Kuhlmann H; Herrmann M; Büchele W
    Dtsch Med Wochenschr; 1984 Jun; 109(24):941-4. PubMed ID: 6734446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Five years' experience with continuous ambulatory or continuous cycling peritoneal dialysis in children.
    von Lilien T; Salusky IB; Boechat I; Ettenger RB; Fine RN
    J Pediatr; 1987 Oct; 111(4):513-8. PubMed ID: 3655981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholesterol ester transfer protein in children on peritoneal dialysis.
    Tanaka Y; Matsuyama T; Ishikura K; Hataya H; Ikeda M; Honda M
    Perit Dial Int; 2004; 24(3):281-6. PubMed ID: 15185777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of dialysis type on serum lipids, apolipoproteins, and lipoproteins.
    Kanbay M; Delibasi T; Kaya A; Aydogan T; Koca C; Akcay A; Duranay M; Yigitoglu R
    Ren Fail; 2006; 28(7):567-71. PubMed ID: 17050239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Higher KT/V urea associated with greater protein catabolic rate and dietary protein intake in children treated with CCPD compared to CAPD. Mid-European Pediatric CPD Study Group (MPCS).
    Schaefer F; Wolf S; Klaus G; Langenbeck D; Mehls O
    Adv Perit Dial; 1994; 10():310-4. PubMed ID: 7999855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.